Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
132M
-
Number of holders
-
198
-
Total 13F shares, excl. options
-
79.5M
-
Shares change
-
+2.53M
-
Total reported value, excl. options
-
$2.98B
-
Value change
-
-$14.5M
-
Put/Call ratio
-
0.97
-
Number of buys
-
104
-
Number of sells
-
-138
-
Price
-
$37.44
Significant Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q4 2016
295 filings reported holding ALNY - ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK as of Q4 2016.
ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) has 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 79.5M shares
of 132M outstanding shares and own 60.46% of the company stock.
Largest 10 shareholders include FMR LLC (12.9M shares), WELLINGTON MANAGEMENT GROUP LLP (12M shares), DODGE & COX (9.2M shares), VANGUARD GROUP INC (5.46M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.16M shares), BAILLIE GIFFORD & CO (3.32M shares), STATE STREET CORP (2.36M shares), BlackRock Fund Advisors (2.1M shares), Slate Path Capital LP (2M shares), and BlackRock Institutional Trust Company, N.A. (1.95M shares).
This table shows the top 198 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.